biotech

Antibody JAA-F11 Inhibits Breast Cancer Metastasis

Filed in archive Drugs, Vaccines and Therapeutics on December 29, 2006

Antibody JAA-F11 Inhibits Breast Cancer Metastasis
In mice trials, a monoclonal antibody named JAA-F11 has been shown to extend the survival of mice with human breast-cancer tumors and to inhibit the cancer's spread to the lungs by more than 50 percent.
JAA-F11, targets a particular disaccharide, an antigen known as TF-Ag, which aids the adhesion and spread of certain cancer cells. While the antibody did not kill the cancer cells, it blocked stages of cancer-cell growth that allow the cells to adhere to organ tissue, the research showed.

Mice with breast-cancer tumors that received the antibody had a median survival time of 72 days, compared to 57 days for the animals that did not receive JAA-F11, the study found. In addition, exposing cultures of tumor cells to the antibody inhibited cell growth by a statistically significant 16 percent.

According to the authors of the study published in the November issue of the journal Neoplasia, JAA-F11 could also increase the efficacy of existing cancer drugs and may be used as a vehicle for drug delivery, since JAA-F11 bind to the tumor cell surface.

[Source: University of Buffalo, Photo: MedLibrary.org]

Permalink: Antibody JAA-F11 Inhibits Breast Cancer Metastasis

Tags: cancer  breast+cancer  antibody  drug+delivery  chemotherapy  biotech  cancer+metastasis  inhibits+breast 

Vote for Antibody JAA-F11 Inhibits Breast Cancer Metastasis:

  • Currently 10.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 10.00 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells